Bristol-Myers Squibb, Ventiv ink multi-year service deal

Bristol-Myers Squibb and Ventiv Pharma Services have signed a multi-year service agreement under which Ventiv will provide a sales force of more than 375 representatives focusing on Cefzil and Tequin.
Under the terms of the agreement, Ventiv Pharma also will provide BMS with the entire field and internal management staff, full operational support to include sales force automation, help desk support and analysis and reporting services, according to a Ventiv statement. Ventiv Pharma is a division of Ventiv Health Inc.